CDMO and CRO selection should be evaluated as a regulatory and quality decision first, and a procurement decision second, using inspection history and oversight model design as the evaluative frame.
White Paper
Your CDMO Is Part of Your Regulatory Strategy
Related Resources
All Resources
white-paper
Project Management
Read More
post
How to Choose a Partner to Optimize INDs
Read More
post
Four Top Roadblocks to Successful IND Applications and How to Overcome Them
Read More
case-study
U.S. Based Independent Biotech Company Finds Success in Syner-G’s Capabilities in Manufacturing for Both Pre-Clinical and Clinical Trials Case Studies
Read More
Let's move from science to success.
Let’s Talk